Jump to content
  • Sign Up
  • Join Our Community!

    Get help in our celiac / gluten-free forum.

  • Jefferson Adams
    Jefferson Adams

    Company Options Promising New Celiac Disease Treatment

    Reviewed and edited by a celiac disease expert.

    Celiac.com 04/01/2011 - Cephalon has signed an agreement that gives the company the option to purchase a potentially promising new treatment for celiac disease from Alba Therapeutics.

    The deal calls for Cephalon to pay Alba a $7 million upfront fee, and to offering funding support for a phase IIb trial of the drug in question, a tight junction modulator known as larazotide acetate.

    The deal allows Cephalon to acquire all assets relating to the treatment for an additional payment of $15 million, within specified time window, once trial data have been published

    Cephalon CEO, Kevin Buchi, said the company's interest is based on encouraging trial data for the drug thus far.

    If larazotide acetate proves to be effective against celiac disease, it "has the potential to be the first pharmacologic therapy available to treat patients who endure this often serious condition," Buchi said.

    Source:

     


    User Feedback

    Recommended Comments



    Join the conversation

    You are posting as a guest. If you have an account, sign in now to post with your account.
    Note: Your post will require moderator approval before it will be visible.

    Guest
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • About Me

    Jefferson Adams is Celiac.com's senior writer and Digital Content Director. He earned his B.A. and M.F.A. at Arizona State University, and has authored more than 2,000 articles on celiac disease. His coursework includes studies in science, scientific methodology, biology, anatomy, medicine, logic, and advanced research. He previously served as SF Health News Examiner for Examiner.com, and devised health and medical content for Sharecare.com. Jefferson has spoken about celiac disease to the media, including an appearance on the KQED radio show Forum, and is the editor of the book "Cereal Killers" by Scott Adams and Ron Hoggan, Ed.D.

  • Related Articles

    Scott Adams
    A little boy with a severe seizure disorder had his wish to have a special bike of his own granted through national children’s charity Kids Wish Network.
    Champaign, IL, August 14, 2010 --(PR.com)-- As a child, Joshua was diagnosed with having Intractable Epilepsy, a disorder in which he experiences seizures that are completely uncontrollable; he currently endures around four m...

    Jefferson Adams
    Celiac.com 01/20/2011 - Over his five years as a participant in Project Bread’s annual Walk for Hunger, 16-year-old high school sophomore, Pierce Keegan came to realize that more needed to be done to supply gluten-free food to people in need.
    “When I was doing the Walk for Hunger, I suddenly thought, ‘What if I needed food? Would I be able to get gluten-free products if I cou...

    Dr. Ron Hoggan, Ed.D.
    This article originally appeared in the Spring 2011 edition of Celiac.com's Journal of Gluten-Sensitivity.
    Celiac.com 09/07/2011 - Through the hard work and concerted efforts of many support groups and individuals throughout the US, along with the generosity of Instituto Di Ricerca in Italy, research funding was accumulated. Early in the Twenty-First Century, under the auspices...

    Jefferson Adams
    Celiac.com 10/29/2013 - In an effort to get a better understanding of the prevalence of celiac disease in Germany, a team of researchers recently conducted a randomly selected population sample.
    The research team included W. Kratzer, M. Kibele, A. Akinli, M. Porzner, B.O. Boehm, W. Koenig, S. Oeztuerk, R.A. Mason, R. Mao, and M.H. Haenle. They are affiliated with the Department...

    Jefferson Adams
    Celiac.com 04/18/2015 - Research is underway on a number of new drugs intended to celiac disease treatment beyond a simple gluten-free diet. However, even though several drugs are in Phase 2 trials and results appear promising, discussion around regulatory endpoints is just beginning.
    A research team recently reviewed endpoints for Phase 2 and 3 trials of new celiac disease...

×
×
  • Create New...